- Report
- February 2026
- 250 Pages
Global
From €4034EUR$4,490USD£3,455GBP
- Report
- August 2026
- 177 Pages
Global
From €5255EUR$5,850USD£4,501GBP
- Report
- June 2026
- 189 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- June 2026
- 188 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- June 2026
- 199 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- June 2026
- 183 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- June 2026
- 198 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- June 2026
- 197 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- June 2026
- 183 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- June 2026
- 199 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- January 2026
- 199 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- January 2026
- 183 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- January 2026
- 180 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- January 2026
- 180 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- January 2026
- 190 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- January 2026
- 189 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- January 2026
- 183 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- January 2026
- 193 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- January 2026
- 196 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- January 2026
- 197 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP

The Organ on Chip (OOC) market is a rapidly growing segment of the biotechnology industry. OOCs are microfluidic devices that replicate the physiological and biochemical functions of human organs. They are used to study the effects of drugs, toxins, and other substances on human organs, as well as to develop new treatments for diseases. OOCs are also used to study the effects of diseases on organs, and to develop new diagnostic tools.
OOCs are becoming increasingly popular due to their ability to provide more accurate and reliable results than traditional animal models. They are also cost-effective and can be used to study a wide range of diseases.
Companies in the OOC market include Emulate, TissUse, Mimetas, CN Bio Innovations, and Hurel Corporation. Show Less Read more